Biologics Segment To Record Fastest Growth In Clinical Trial Supplies Market

By Author: Shreya
Total Articles: 19
Comment this article

Meticulous Research®—a leading global market research company, published a research report titled ‘Clinical Trial Supplies Market by Phase (I–IV) Service (Manufacturing, Packaging, Logistic, Documentation) Type (Biologic, Small-molecule, Medical Device) Therapy Area (Oncology, Cardiology, CNS, Immunology, Respiratory) End User - Global Forecast to 2031.’
According to this latest publication from Meticulous Research®, by 2031, the Clinical Trial Supplies Market is expected to reach about $5.59 billion, growing close to 7.7% a year. A few things are driving this. More trials are being run, and many are now set up in decentralized models. Drug makers are also spending heavily on research, which creates demand for supply services. The rise of generics and biopharma adds to that, and it means companies need solid logistics, packaging, and materials support. That said, the road is not smooth. Developing drugs costs a lot, and that slows down progress. Still, new chances are opening in emerging economies, and patent expirations give room for fresh products. On the other hand, shifting rules and failed studies, especially ...
... in rare disease areas, remain tough barriers. For firms handling clinical trial manufacturing and supplies, the challenge is to stay flexible while making the most of these new opportunities.

Key Players

The key players operating in the global clinical trial supplies market are Catalent, Inc. (U.S.), NUVISAN GmbH (Germany), Thermo Fisher Scientific Inc. (U.S.), Almac Group (U.K.), Eurofins Scientific SE (Luxembourg), Parexel International (MA) Corporation (U.S.), Marken (U.S.), Biocair International Limited (U.K.), KLIFO (Denmark), Piramal Pharma Limited (India), Movianto Group (U.K.), and ICON plc (Ireland).

Clinical Trial Supplies Market: Future Outlook

The global clinical trial supplies market is segmented by Clinical Phase (Phase I, Phase II, Phase III, Phase IV), Services (Manufacturing, Packaging & labeling, Logistics & Distribution, Documentation, and Other Services), Type (Medical Devices, Biologics, and Small Molecules), Therapeutic Area (Cardiology, Infectious Diseases, Oncology, CNS, Inflammation & Immunology, Metabolic Disorders, Respiratory Disorders, and Other Therapeutic Areas), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Medical Device Manufacturers, and Clinical Research Organizations), and Geography. The study also evaluates industry competitors and analyzes the market at the global and regional levels.

Phase III Trials to Drive Strong Growth in the Clinical Trial Supplies Market

In the Clinical Trial Supplies Market, phase III studies are expected to grow the fastest over the next few years. These trials are big, costly, and often have high failure rates. The main problem is recruiting patients. Companies need large numbers of participants who fit very specific criteria, and that is rarely easy. Because of this, many sponsors are turning to clinical trial supply services to make recruitment smoother and to keep studies running on schedule. The demand for reliable clinical trial logistics is also rising, since materials must reach multiple sites safely. Along with this comes the need for proper clinical trial packaging and the right clinical trial materials to match strict study designs. Providers of clinical trial manufacturing and supply solutions are becoming more important, helping drug developers manage the complexity of phase III.

Rising Trial Volumes Boost Demand for Clinical Trial Logistics and Supply Services

In 2024, the logistics and distribution segment are likely to take the biggest share of the Clinical Trial Supplies Market. The reason is simple more trials mean more drugs and materials moving around, and that needs proper handling. Good clinical trial logistics makes sure drugs do not pile up where they are not needed, and at the same time avoids shortages. That helps cut waste and keeps studies running smoothly. Transparency is another big factor. With tracking tools, sponsors can see where their clinical trial materials are at any time. This has made logistics and distribution services more attractive. These services also cover safe clinical trial packaging and compliance rules. With demand for reliable clinical trial supply services on the rise, companies that combine logistics with clinical trial manufacturing are expected to benefit the most.

Biologics Segment Set to Record Fastest Growth in the Clinical Trial Supplies Market

In the Clinical Trial Supplies Market, the biologics segment is expected to see the fastest growth in the coming years. Biologics are harder to develop than traditional drugs, and their success rates are low. Because of this, many companies now depend more on clinical trial supply services to manage the added complexity. These products need consistent quality. Even small changes during production can cause setbacks or rejection. That is why reliable clinical trial manufacturing and high-quality clinical trial materials are so important. Smooth clinical trial logistics and secure clinical trial packaging also help keep biologics stable and compliant while they move across study sites. The risks remain high only about 9.1% of biologics get through phase I, compared with 9.7% for vaccines but demand for specialized supply solutions is still rising as trials expand.

Logistics and Distribution Take the Lead in the Clinical Trial Supplies Market

In 2024, the logistics and distribution segment are likely to take the biggest share of the Clinical Trial Supplies Market. The reason is simple: more trials mean more drugs and clinical trial materials moving around, and that requires better handling. Strong clinical trial logistics makes sure there are not piles of drugs where they are not needed, while also avoiding shortages at busy sites. That balance cuts down on waste and keeps studies moving. Transparency is another big driver. With tracking tools, sponsors can see where supplies are in real time, which makes clinical trial supply services more attractive. These services also cover safe clinical trial packaging and help with compliance. As demand grows, companies that bring together logistics, distribution, and clinical trial manufacturing are in the best position to benefit.

Rising Complexity of Biologics Drives Demand for Clinical Trial Supply Services

In the Clinical Trial Supplies Market, the biologics segment is expected to grow the fastest over the coming years. Biologics are complex and much harder to develop than traditional drugs, and approval rates remain low. That is why more companies are leaning on clinical trial supply services to deal with the extra challenges. Consistency is a big issue. Small changes in production can cause setbacks, which makes reliable clinical trial manufacturing essential. Sponsors also need strong clinical trial logistics to move sensitive biologics safely between sites, along with secure clinical trial packaging to keep products stable and compliant. Handling the right clinical trial materials is equally important, as rejection risks are high. To put it in perspective, only about 9.1% of biologics make it past phase I trials, compared with 9.7% for vaccines. Even with the risks, demand for specialized supply solutions is rising as biologics continue to expand.

Oncology Segment Leads the Clinical Trial Supplies Market with Rising Cancer Burden

In 2024, the oncology segment is expected to hold the biggest share of the Clinical Trial Supplies Market. This is not surprising. Cancer cases are rising worldwide, and oncology trials are known for low success rates. On top of that, more cancer drugs are entering the clinical pipeline, and governments are putting extra money into research. For example, in June 2023, the University of Birmingham in the U.K. received a $12 million (£10 million) grant from Cancer Research UK to renew its Cancer Research Clinical Trials Unit. The unit now supports more than 100 national and international studies. Support like this makes oncology a heavy user of clinical trial supply services. Running these studies also means strong clinical trial logistics are needed to move sensitive drugs safely between sites. Secure clinical trial packaging is key to protect products, while consistent clinical trial manufacturing and high-quality clinical trial materials help reduce delays. Even with the risks, oncology continues to drive demand for specialized supply solutions.

Rising Research Funding Boosts Demand for Clinical Trial Supply Services

By 2024, it looks like pharmaceutical and biotechnology companies will hold the biggest share of the clinical trial supplies market. The reason is clear—drug developers are investing more in personalized medicine, and funding for research keeps climbing. In fact, the NIH budget went up from about $33 billion in 2015 to $42 billion in 2021, which shows how much weight governments are putting behind new therapies. With more labs running studies, the demand for clinical trial supply services is rising fast. These companies now depend on reliable clinical trial logistics, safe clinical trial packaging, and high-quality clinical trial materials to keep projects moving. Strong clinical trial manufacturing support also makes sure that studies do not slow down once patient recruitment begins.

Strong R&D Investments Drive Growth in Clinical Trial Supplies Market

This report looks at the market across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. It covers countries such as the U.S., Canada, Germany, France, the U.K., Italy, Spain, China, Japan, India, Brazil, and Mexico. For 2024, North America is set to take the lead in the clinical trial supplies market. The U.S. and Canada have many of the big pharma and biotech firms, so it is not surprising. Labs are well established, and companies here spend a lot on R&D. In fact, research budgets in this region are usually higher than in most parts of the world. Another factor is the supply chain materials move quickly between trial sites, which keeps studies on track. All of this explains why North America holds the largest share.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5072

Key questions answered in the report-

How do decentralized trials contribute to the rising demand for clinical trial supply services?
What role do generics and biopharma growth play in shaping the market outlook?
What are the key barriers holding back faster growth in the clinical trial supplies market?
How do shifting regulatory policies affect companies in clinical trial logistics and manufacturing?
Why are Phase III clinical trials expected to drive the fastest growth in the market?
How do patient recruitment challenges in Phase III studies affect supply chain needs?
How do companies like Catalent, Thermo Fisher, and Almac Group strengthen their market presence?
Which emerging economies present the biggest opportunities for clinical trial supplies providers?
Why is the logistics & distribution segment expected to hold the largest share in 2024?
How are tracking tools improving transparency in clinical trial logistics?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research